FindTrial
Sign In

Safety and efficacy of 25G vitrectomy surgery for malignant glaucoma in pseudophakia: a retrospective study based on medical records

Safety and efficacy of 25G vitrectomy surgery for malignant glaucoma in pseudophakia: a retrospective study based on medical records

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025126
Enrollment
Unknown
Registered
2019-08-12
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant glaucoma

Interventions

1:N/A

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 78 Years

Inclusion criteria

Inclusion criteria: The clinical data of patients with malignant glaucoma after cataract phacoemulsification and intraocular lens implantation were collected in department of ophthalmology at the First Affiliated Hospital of Anhui Medical University, and to observe the safety and effectiveness of 25G vitrectomy for this complication.

Exclusion criteria

Exclusion criteria: Pupil block, suprachoroidal leakage or bleeding, and so on were excluded.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuity (BCVA);—

Countries

China

Contacts

Public ContactShouling Li

The First Affiliated Hospital of Anhui Medical University

379620200@qq.com+86 0551-2991129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026